Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 7th, 2019 |
Personalized Strategies to Manage Symptoms of Chronic Illness (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Health Promotion Among Racial and Ethnic Minority Males (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2019 |
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2019 |
Personalized Strategies to Manage Symptoms of Chronic Illness (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2019 |
Innovative Questions in Symptom Science and Genomics (R01 Clinical Trial Optional) |
National Institutes of Health |
February 21st, 2018 |
Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) |
National Institutes of Health |
January 10th, 2018 |
Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) |
National Institutes of Health |
May 7th, 2019 |
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2019 |
Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2019 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2019 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional) |
National Institutes of Health |
|
September 7th, 2018 |
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) |
National Institutes of Health |
February 14th, 2020 |
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required) |
National Institutes of Health |
February 21st, 2018 |
Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 22nd, 2018 |
NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
January 10th, 2018 |
Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42) |
National Institutes of Health |
September 7th, 2018 |
Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2018 |
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) |
National Institutes of Health |
January 7th, 2019 |
Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) |
National Institutes of Health |